<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Exp Diabetes Res</journal-id><journal-id journal-id-type="publisher-id">EDR</journal-id><journal-title>Experimental Diabetes Research</journal-title><issn pub-type="ppub">1687-5214</issn><issn pub-type="epub">1687-5303</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1155/2008/421287</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in <italic>&#x003b2;</italic>-Cell Death in Type 2 Diabetes Mellitus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Khemt&#x000e9;mourian</surname><given-names>Lucie</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Antoinette Killian</surname><given-names>J.</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>H&#x000f6;ppener</surname><given-names>Jo W. M.</given-names></name><xref ref-type="aff" rid="I2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Engel</surname><given-names>Maarten F. M.</given-names></name><xref ref-type="aff" rid="I1"><sup>1, 2</sup></xref><xref ref-type="aff" rid="I2"/><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Metabolic and Endocrine Diseases, Division of Biomedical Genetics, University Medical Center Utrecht, P.O. Box 85090, 3508 AB Utrecht, The Netherlands</aff><aff id="I2"><sup>2</sup>Research group Chemical Biology and Organic Chemistry, Bijvoet Institute and Institute of Biomembranes, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands</aff><author-notes><corresp id="cor1">*Maarten F. M. Engel: <email>m.engel@leeds.ac.uk</email></corresp><fn fn-type="other"><p>Recommended by Per Westermark</p></fn></author-notes><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>6</day><month>5</month><year>2008</year></pub-date><volume>2008</volume><elocation-id>421287</elocation-id><history><date date-type="received"><day>9</day><month>10</month><year>2007</year></date><date date-type="accepted"><day>18</day><month>2</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Lucie Khemt&#x000e9;mourian et al.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>The presence of fibrillar protein deposits (amyloid) of human islet amyloid polypeptide (hIAPP) in the pancreatic islets of Langerhans is thought to be related to death of the insulin-producing islet <italic>&#x003b2;</italic>-cells in type 2 diabetes mellitus (DM2). The mechanism of hIAPP-induced <italic>&#x003b2;</italic>-cell death is not understood. However, there is growing evidence that hIAPP-induced disruption of <italic>&#x003b2;</italic>-cell membranes is the cause of hIAPP cytotoxicity. Amyloid cytotoxicity by membrane damage has not only been suggested for hIAPP, but also for peptides and proteins related to other misfolding diseases, like Alzheimer's disease, Parkinson's disease, and prion diseases. Here we review the interaction of hIAPP with membranes, and discuss recent progress in the field, with a focus on hIAPP structure and on the proposed mechanisms of hIAPP-induced membrane damage in relation to <italic>&#x003b2;</italic>-cell death in DM2.</p></abstract></article-meta></front><body><sec sec-type="section" id="sec1"><title>1. INTRODUCTION</title><p>Long before discovery of the primary structure of the main component of amyloid in the islets of Langerhans, detailed ultra structural investigations had revealed that islet amyloid was often in contact with <italic>&#x003b2;</italic>-cell membranes [<xref ref-type="bibr" rid="B1">1</xref>]. In fact, it was found that amyloid fibrils were oriented perpendicular to the membrane of islet <italic>&#x003b2;</italic>-cells, with some fibril bundles sticking into membrane invaginations [<xref ref-type="bibr" rid="B1">1</xref>]. In 1987, the main component of islet amyloid was identified as a 37-amino acid residue peptide called islet amyloid polypeptide (IAPP) or amylin [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>]. Since then, the presence of IAPP amyloid at the <italic>&#x003b2;</italic>-cell membrane, and the concomitant morphological changes of these membranes, has been reported frequently [<xref ref-type="bibr" rid="B4">4</xref>&#x02013;<xref ref-type="bibr" rid="B9">9</xref>]. These reports have contributed to the current hypothesis that the interaction between IAPP and cellular membranes could be a cause of IAPP cytotoxicity and <italic>&#x003b2;</italic>-cell death in DM2. Before reviewing IAPP-membrane interactions, we will briefly discuss the present knowledge on IAPP fibril formation.</p></sec><sec sec-type="section" id="sec2"><title>2. IAPP FIBRIL FORMATION</title><sec sec-type="subsection" id="subsec2.1"><title>2.1. From monomer to fibril</title><p>The amino acid sequence of IAPP varies slightly from organism to organism [<xref ref-type="bibr" rid="B10">10</xref>]. For instance, six residues are different between human IAPP (hIAPP) and mouse IAPP (mIAPP) (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). Importantly, the latter does not aggregate into amyloid fibrils, and amyloid is generally not observed in the pancreas of wild-type mice. Nevertheless, transgenic mouse models that express human IAPP develop fibrillar deposits and exhibit signs of diabetes [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>The in vitro aggregation and fibril formation of hIAPP have been studied extensively in the last years [<xref ref-type="bibr" rid="B12">12</xref>&#x02013;<xref ref-type="bibr" rid="B22">22</xref>]. In most of these studies, hIAPP aggregation is initiated by dilution of, usually synthetic, monomeric hIAPP into a physiological buffer. This results in the &#x0201c;spontaneous&#x0201d; aggregation of hIAPP monomers into amyloid fibrils, as can be observed, for example, by electron microscopy. The in vitro aggregation of hIAPP is typically completed in a few hours, depending amongst others on peptide concentration and presence of lipids [<xref ref-type="bibr" rid="B18">18</xref>]. This is significantly faster than the aggregation of most other amyloidogenic peptides. Fibril formation of IAPP, as well as of some other amyloidogenic peptides, generally occurs via a nucleation dependent aggregation process [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B23">23</xref>]. This means that the formation of a nucleus, usually a slow step, is required for initiation of the growth of stable fibrils. The nucleus is an ordered oligomeric hIAPP species that can serve as a template for fibrillar hIAPP. The kinetics of hIAPP fibril growth can be monitored in time by the commonly used method of specific binding of the fluorescent molecule Thioflavin T (ThT) to amyloid fibrils [<xref ref-type="bibr" rid="B24">24</xref>]. A kinetic trace of hIAPP fibril growth shows a lag phase and a sigmoidal transition that are typical for fibril growth of amyloidogenic proteins and peptides (see <xref ref-type="fig" rid="fig2">Figure 2</xref>) [<xref ref-type="bibr" rid="B23">23</xref>]. After dilution of initially monomeric hIAPP in buffer, the thermodynamically unfavourable process of nucleation occurs, although the initial horizontal baseline of the ThT curve indicates that no fibrils are formed in the beginning (lag phase). The sigmoidal increase in the ThT curve indicates propagation of fibril growth with consumption of monomer. Next to the monomeric and fibrillar states of hIAPP, several intermediate (oligomeric) states have been observed, as will be discussed later. Elongation of fibrils proceeds via addition of monomers or oligomers to both fibril ends.</p></sec><sec sec-type="subsection" id="subsec2.2"><title>2.2. Three-dimensional molecular structure of hIAPP</title><p>The three-dimensional structure of amyloid fibrils, and lately also the structure of monomers and oligomers, has been the subject of research into the molecular background of amyloid diseases. However, only little structural information is available for the IAPP monomer, oligomer, and fibril. In 1992, the first, limited information of the three-dimensional structure of soluble hIAPP was obtained [<xref ref-type="bibr" rid="B25">25</xref>]. It was shown that hIAPP exhibits a random coil structure with small components of <italic>&#x003b1;</italic>-helical and <italic>&#x003b2;</italic>-sheet conformations. Recent studies confirmed that soluble hIAPP has mainly unordered backbone structure [<xref ref-type="bibr" rid="B26">26</xref>&#x02013;<xref ref-type="bibr" rid="B28">28</xref>]. In contrast, hIAPP dissolved in the organic solvent trifluoroethanol (TFE, a membrane mimicking solvent) predominantly adopts an <italic>&#x003b1;</italic>-helical conformation [<xref ref-type="bibr" rid="B25">25</xref>]. Our observations have indicated that hIAPP dissolved in TFE initially adopts <italic>&#x003b1;</italic>-helical structure, before transforming into <italic>&#x003b2;</italic>-sheet structure (unpublished results). These observations suggest that hIAPP could also adopt <italic>&#x003b1;</italic>-helical structure in a membrane environment.</p><p>hIAPP oligomers or aggregates ranging from dimers up to 6000 molecules have been reported by several research groups [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B29">29</xref>&#x02013;<xref ref-type="bibr" rid="B31">31</xref>]. These oligomers appear to represent intermediates on the path to fibril formation. There are recent indications that hIAPP oligomers, in presence of membranes, exhibit <italic>&#x003b1;</italic>-helical structure [<xref ref-type="bibr" rid="B28">28</xref>]. This is surprising since it would seem thermodynamically unfavourable for a monomer with random coil structure to first adopt <italic>&#x003b1;</italic>-helical structure before changing into <italic>&#x003b2;</italic>-sheet rich fibrillar structure. Aggregation intermediates have been observed for many types of amyloid proteins, such as <italic>&#x003b1;</italic>-synuclein and A<italic>&#x003b2;</italic> [<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>]. Glabe and coworkers have produced a conformation-dependent antibody that is specific for soluble oligomers and does not recognize natively folded proteins, monomer, or fibrils [<xref ref-type="bibr" rid="B34">34</xref>]. They showed that this antibody recognizes soluble oligomers from a wide variety of amyloid-forming peptides and proteins such as hIAPP, Prion 106&#x02013;126, human insulin, A<italic>&#x003b2;</italic> peptide, and polyglutamine, which suggests that these oligomers might have a common structure.</p><p>The three-dimensional structure of hIAPP fibrils has been studied by various high-resolution techniques, like electron microscopy, X-ray diffraction, electron diffraction, and electron paramagnetic resonance [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B35">35</xref>&#x02013;<xref ref-type="bibr" rid="B38">38</xref>]. These studies clearly reveal that hIAPP fibrils contain a significant amount of well-ordered cross-<italic>&#x003b2;</italic> structure, typical of amyloid fibrils. During fibril formation, hIAPP undergoes a conformational change from random coil to a mixture of <italic>&#x003b2;</italic>-sheet and <italic>&#x003b1;</italic>-helical structure [<xref ref-type="bibr" rid="B26">26</xref>]. These results are consistent with the work of Kayed [<xref ref-type="bibr" rid="B15">15</xref>], who also measured a random coil to <italic>&#x003b2;</italic>-sheet transition for hIAPP fibril formation. hIAPP fibrils are polymorphic, ranging from thin protofilaments with a diameter of about 5 nm to thicker fibrils with diameter of up to 15 nm that appear to be rope-like bundles of protofilaments. The predominant type of fibril contains three protofilaments in a left-handed coil with a pitch of 25&#x02013;50 nm.</p></sec><sec sec-type="subsection" id="subsec2.3"><title>2.3. Which amino acid residues are important for hIAPP fibril formation?</title><p>Structural studies have shown that amino acid residues 20&#x02013;29 of hIAPP are crucial for amyloid formation [<xref ref-type="bibr" rid="B12">12</xref>]. A proline scan of this decamer (hIAPP20&#x02013;29) has demonstrated that substitution of a single proline at either position 22, 24 or at positions 26&#x02013;28 leads to a drastic reduction of amyloid formation [<xref ref-type="bibr" rid="B39">39</xref>]. Note that three of the six differences between hIAPP and the nonamyloidogenic mIAPP involve a proline, a residue that is predicted to disrupt ordered structure, like the <italic>&#x003b2;</italic>-sheet structure in amyloid fibrils.</p><p>Currently, research groups are developing molecules in an attempt to reduce hIAPP-induced <italic>&#x003b2;</italic>-cell death by inhibiting hIAPP fibril formation. Some of these &#x0201c;inhibitors&#x0201d; are based on synthetically modified hIAPP peptides or hIAPP fragments that are not able to form fibrils themselves, but are suggested to bind to, and to stop the elongation of growing hIAPP fibrils [<xref ref-type="bibr" rid="B40">40</xref>&#x02013;<xref ref-type="bibr" rid="B42">42</xref>]. A recent study indicated that a single amino acid substitution in hIAPP, where Ile on position 26 is replaced by Pro (I26P), yields a potent fibrillization inhibitor [<xref ref-type="bibr" rid="B43">43</xref>].</p><p>Although residues 20&#x02013;29 play an important role in hIAPP fibril formation, these may not be the only residues involved. It has been hypothesized that aromatic-aromatic interactions are also important in hIAPP fibril formation [<xref ref-type="bibr" rid="B44">44</xref>]. Human IAPP contains three aromatic residues at positions 15, 23, and 37 (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). The aromatic-aromatic and aromatic-hydrophobic interactions in amyloid formation were studied using a hIAPP triple mutant [<xref ref-type="bibr" rid="B45">45</xref>]. The triple mutant F15L/F23L/Y37L, lacking aromatic residues, still forms amyloid fibrils in vitro, indicating that the aromatic residues are not essential in hIAPP fibril formation. However, the substitution decreases the rate of fibril formation and alters the tendency of fibrils to aggregate. Some studies demonstrate that the amino acid region from residues 11 to 20 is also important for hIAPP fibril formation [<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>]. A recent study shows that the hIAPP fragment consisting of residues 14&#x02013;20 can form amyloid fibrils [<xref ref-type="bibr" rid="B38">38</xref>].</p><p>hIAPP contains a single histidine at position 18 (see <xref ref-type="fig" rid="fig1">Figure 1</xref>), which is the only residue in this peptide that has a charge that depends on pH in a physiological pH range. Consequently, fibril formation of hIAPP could depend on the pH. A recent study showed that hIAPP fibril formation is faster at a lower pH (4.0) than at a higher pH (8.8) [<xref ref-type="bibr" rid="B48">48</xref>]. This could be important in a physiological context since in the <italic>&#x003b2;</italic>-cell granules of the pancreas, where hIAPP is stored, the pH is 5.5, but when hIAPP is released into the extracellular compartment, it experiences a pH of 7.4 [<xref ref-type="bibr" rid="B49">49</xref>].</p><p>Another characteristic of hIAPP is the intramolecular disulfide bond between cysteines residues 2 and 7 (see <xref ref-type="fig" rid="fig1">Figure 1</xref>). The disulfide does not contribute to the amyloid fiber core structure; however it somehow must play a central role in the assembly mechanism, since loss of the disulfide significantly reduces fibril formation [<xref ref-type="bibr" rid="B20">20</xref>].</p></sec></sec><sec sec-type="section" id="sec3"><title>3. hIAPP AGGREGATION AND FIBRIL FORMATION IN THE PRESENCE OF MEMBRANES</title><sec sec-type="subsection" id="subsec3.1"><title>3.1. Membrane phospholipids catalyse hIAPP fibril formation</title><p>It has been observed that phospholipid membranes promote the aggregation of hIAPP [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>]. In the presence of phospholipids, the kinetic profile of hIAPP fibril growth is characterized by a reduction in the lag time resulting in earlier fibril formation [<xref ref-type="bibr" rid="B50">50</xref>]. Cellular membranes could accelerate hIAPP fibril formation by enhancing nucleation. The lipid composition may play an important role in this process, since it has been demonstrated that hIAPP aggregation is accelerated in the presence of membranes that contain negatively charged lipids such as 1,2-dioleoyl-<italic>sn</italic>-glycero-3-phospho-L-serine (DOPS) or 1,2-Dioleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)](DOPG) [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>]. In the presence of such membranes, hIAPP fibril formation occurs within a few minutes as opposed to a few hours in the absence of membranes [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B50">50</xref>]. A membrane-induced change in the conformation in hIAPP could possibly result in formation and/or stabilization of a nucleus, which could in turn result in acceleration of hIAPP fibril formation. Hence, elucidation of the conformation of hIAPP in interaction with the membrane is an important issue. Knowledge of this conformation would give valuable insights into the mechanism of membrane damage and would aid in developing new drugs and/or finding new targets for the treatment of DM2.</p></sec><sec sec-type="subsection" id="subsec3.2"><title>3.2. Insight in the conformation of membrane-interacting hIAPP</title><p>Recently, studies have been performed to determine the conformation of hIAPP that interacts with model membranes, that is, large unilamellar vesicles (LUVs) [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B52">52</xref>]. In these studies, the LUVs are composed of a combination of a neutral phospholipid, for instance, 1,2-dioleoyl-<italic>sn</italic>-glycero-3-phosphocholine (DOPC), and a negatively charged phospholipid, for instance, 1,2-dioleoyl-<italic>sn</italic>-glycero-3-phospho-L-serine (DOPS). In the presence of LUVs, hIAPP initially displays <italic>&#x003b1;</italic>-helical structure [<xref ref-type="bibr" rid="B27">27</xref>], corresponding with the structure of hIAPP in the membrane-mimicking solvent TFE [<xref ref-type="bibr" rid="B25">25</xref>]. However, after 40 minutes incubation with LUVs, the conformation of hIAPP changes to predominantly <italic>&#x003b2;</italic>-sheet conformation, characteristic of fibril formation [<xref ref-type="bibr" rid="B27">27</xref>]. Recently, the structure of hIAPP in membrane bilayers was studied using microscopy techniques [<xref ref-type="bibr" rid="B53">53</xref>]. It was found that hIAPP forms pores that are composed of five subunits, in which each subunit is suggested to represent an hIAPP monomer. This hIAPP morphology was connected to channel-like behavior in planar bilayers, indicating that these oligomeric hIAPP pores could incorporate in membranes and change their barrier properties. Unfortunately, high-resolution structural information of hIAPP in a membrane environment is still lacking, mainly because of the instability of the membrane-interacting hIAPP aggregates. Preliminary results of our group indicate that hIAPP fibrils grown in the presence of phospholipids have the same characteristic structure as fibrils formed in the absence of lipids.</p></sec><sec sec-type="subsection" id="subsec3.3"><title>3.3. Which residues are important in the interaction with membrane?</title><p>It is likely that the presence of membranes causes additional residues in IAPP to be involved in fibril formation, as compared to the situation without membranes. Several residues that are important for hIAPP-membrane interactions can be identified. It can be anticipated that the positively charged residues, which are all located at the N-terminal part of hIAPP at positions 1, 11, and 18 (see <xref ref-type="fig" rid="fig1">Figure 1</xref>), will be important in the interaction of hIAPP with negatively charged phospholipid membranes. Indeed, there are indications that hIAPP molecules cluster at the membrane surface, prior to fibrillogenesis, with their N-termini oriented towards the membrane [<xref ref-type="bibr" rid="B50">50</xref>]. More recently, it was shown that an N-terminal hIAPP fragment (hIAPP1&#x02013;19) has a significantly higher ability to insert in phospholipid monolayers than a fragment from the central, amyloidogenic region of hIAPP (hIAPP20&#x02013;29) [<xref ref-type="bibr" rid="B54">54</xref>]. These findings suggest that the N-terminal part of hIAPP, whilst not significantly involved in hIAPP fibril growth, is important in light of hIAPP-membrane interactions.</p></sec></sec><sec sec-type="section" id="sec4"><title>4. MECHANISM OF CYTOTOXICITY</title><p>In 1993, work on the amyloidogenic Alzheimer's related peptide Abeta had indicated that an amyloidogenic protein can form ion-selective membrane channels, providing a first hypothesis for the mechanism of amyloid (neuro)toxicity [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>]. The observations that IAPP fibrils are located at the cellular membrane in the Islets of Langerhans and that this is accompanied by alterations in membrane morphology [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B4">4</xref>&#x02013;<xref ref-type="bibr" rid="B9">9</xref>] made researchers hypothesize that the membrane might be the target of cytotoxic IAPP and that this could cause death of the insulin producing <italic>&#x003b2;</italic>-cells, similar to Abeta neurotoxicity in Alzheimer's disease. The first experimental evidence that indeed hIAPP can cause membrane disruption came from work by the Kagan group [<xref ref-type="bibr" rid="B57">57</xref>]. It was found from experiments with planar lipid bilayers that synthetic hIAPP forms ion-permeable channels &#x0201c;pores&#x0201d; in the membrane, whereas the nonamyloidogenic mouse IAPP does not form channels. Mature hIAPP fibrils were found to be less cytotoxic; moreover, they did not cause significant membrane disruption in comparison to oligomeric hIAPP [<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>]. Still, the exact mechanism of hIAPP-induced membrane disruption is far from understood, and various mechanisms have been hypothesized during the last 10 years [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B60">60</xref>&#x02013;<xref ref-type="bibr" rid="B63">63</xref>]. It is, for example, unclear what the exact nature of the hIAPP species that interacts with or even disrupts membranes is. The main hypothesis, based on in vitro evidence, suggests a major role for a specific prefibrillar hIAPP aggregate, commonly known as hIAPP oligomer, as the membrane-disrupting species [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B64">64</xref>]. The various suggested mechanisms for hIAPP-induced membrane disruption will be discussed below.</p><sec sec-type="subsection" id="subsec4.1"><title>4.1. hIAPP oligomers cause membrane damage and are cytotoxic</title><p>Recently, it has been suggested that prefibrillar aggregates (or oligomers), formed early during aggregation and not mature amyloid fibrils are the cytotoxic species in protein misfolding diseases [<xref ref-type="bibr" rid="B65">65</xref>]. Considering amyloid cytotoxicity in DM2, the prevailing view is that IAPP-induced membrane damage, and concomitant <italic>&#x003b2;</italic>-cell death, is caused by cytotoxic hIAPP oligomers [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B64">64</xref>]. There are indications that these oligomers form ion channels [<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B57">57</xref>], as has been suggested for other amyloidogenic proteins [<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B66">66</xref>]. Other studies indicate that hIAPP oligomer-induced membrane damage is not specific for ions [<xref ref-type="bibr" rid="B31">31</xref>] but results in membrane leakage of molecules with a size of up to 600 Da (Calcein), indicating a general membrane disruption mechanism by hIAPP oligomers [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B67">67</xref>].</p><p>Small hIAPP aggregates have been shown to be cytotoxic in cell cultures, and these aggregates were also able to destabilize model membranes [<xref ref-type="bibr" rid="B7">7</xref>]. Similarly, oligomeric hIAPP was found to form membrane pores, allowing molecules with the size of a calcium ion to pass. These pores disappeared, and membrane damage decreased, when hIAPP fibrils grew and oligomers were consumed [<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B60">60</xref>]. Electron microscopy analysis showed that hIAPP formed spherical shapes with a diameter of 3 to 20 nm, consistent with the presence of hIAPP oligomers [<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B60">60</xref>]. In a test tube, oligomeric hIAPP can be prepared under specific experimental conditions. Addition of such preparations to human neuroblastoma cells that were loaded with fluorescent dye resulted in the cellular leakage of this dye [<xref ref-type="bibr" rid="B59">59</xref>]. This indicates that hIAPP oligomers, when applied to the outside of cells, are cytotoxic via a general membrane destabilizing effect and not via a specific ion pore. The monomeric and fibrillar form of hIAPP clearly did not have this effect. Later it was also shown that when applied from the inside of cells, using cells that overexpress hIAPP, the hIAPP oligomers are also able to perform their cytotoxic action [<xref ref-type="bibr" rid="B64">64</xref>]. Recently, it has been suggested that ER and mitochondrial membranes might be the target of cytotoxic hIAPP, resulting in ER stress and <italic>&#x003b2;</italic>-cell apoptosis [<xref ref-type="bibr" rid="B68">68</xref>]. Moreover, intracellular hIAPP oligomers were indirectly demonstrated in the pancreatic <italic>&#x003b2;</italic>-cells of hIAPP-transgenic mice using an oligomer-specific antibody [<xref ref-type="bibr" rid="B69">69</xref>]. The latter study also showed that oligomer-specific antibodies could not prevent hIAPP-induced <italic>&#x003b2;</italic>-cell death, indicating that toxic events might occur inside the cell.</p><p>The exact mechanism of membrane disruption by hIAPP oligomers is not known. Some groups show that preassembled hIAPP oligomers disrupt membranes [<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B60">60</xref>], whereas others suggest that hIAPP monomers first interact with the membrane and only then form oligomeric hIAPP with membrane disrupting capacity [<xref ref-type="bibr" rid="B28">28</xref>]. These two models of membrane damage by hIAPP oligomers have been schematically depicted in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p><p>In conclusion, many observations indicate that hIAPP oligomers are a likely candidate for inducing cell death. In contrast, hIAPP fibrils are found not to damage membranes and could in fact be the result of a physiological mechanism in which toxic oligomer species are disposed of in a nontoxic, fibrillar form.</p></sec><sec sec-type="subsection" id="subsec4.2"><title>4.2. Membrane damage by fibril growth at the membrane</title><p>In addition to the hypothesis that oligomers are the toxic species, recent reports suggest also other mechanisms for hIAPP cytotoxicity. One such hypothesis is that membrane damage is not caused by a specific hIAPP species, such as an oligomer, but by the process of fibril growth at the cellular membrane. There are several recent indications that growth of hIAPP fibrils at the membrane can cause membrane damage. In this model, the initial steps of the interaction of hIAPP with membranes are adsorption, followed by insertion of hIAPP into the membrane, either as monomer or as oligomer (see <xref ref-type="fig" rid="fig3">Figure 3</xref>). The interaction of monomeric hIAPP with membranes is likely as monomeric hIAPP has a strong tendency to insert in phospholipid monolayers [<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B54">54</xref>]. In the next step, interactions of membrane-located hIAPP species with each other, or with hIAPP species in solution, lead to growth of fibrils at the membrane (model 3 in <xref ref-type="fig" rid="fig3">Figure 3</xref>). The mechanism of membrane damage could entail growth of a rigid hIAPP fibril on a flexible phospholipid bilayer, which would result in a forced change in membrane curvature. This change in membrane curvature leads to deformation of the shape of the membrane. Interestingly, disruption, blebbing and vesicle budding of cell membranes in the presence of synthetic [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>] and cell-derived hIAPP [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B70">70</xref>] have been noticed in many studies. Our recent results indicate that the kinetics of membrane damage is very similar to the kinetics of fibril formation (see <xref ref-type="fig" rid="fig2">Figure 2</xref>). Both processes, fibril formation and membrane damage, were characterized by the presence of a lag phase and a strong enhancing effect on the kinetics upon the addition of seeds [<xref ref-type="bibr" rid="B71">71</xref>]. In case of the Alzheimer's disease-related Abeta peptide, it has been suggested recently that not a particular species but ongoing amyloid fibrillogenesis is responsible for membrane damage [<xref ref-type="bibr" rid="B72">72</xref>]. Together, these notions suggest that a cytotoxic mechanism based on fibril growth at the membrane could represent a common mechanism for amyloid-induced cell death. Finally, another factor that could contribute to membrane damage by fibril growth is uptake of membrane lipids in amyloid, a phenomenon that has been observed, both in vitro [<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>] and in vivo [<xref ref-type="bibr" rid="B75">75</xref>].</p></sec></sec><sec sec-type="section" id="sec5"><title>5. INITIATION OF HARMFUL IAPP-MEMBRANE INTERACTIONS IN DM2</title><p>Since the combination of hIAPP and membranes in nondiabetic people does not normally result in <italic>&#x003b2;</italic>-cell death; certain DM2-related conditions should exist that initiate hIAPP-induced membrane damage. An increase in the level of hIAPP, which is coproduced and cosecreted with insulin, in a state of insulin resistance, could initiate hIAPP fibril formation. More specific, an altered ratio of insulin to hIAPP, as observed in diabetic patients [<xref ref-type="bibr" rid="B16">16</xref>], could lead to a decrease of the inhibitory effect of insulin on hIAPP amyloid fibril formation. This inhibitory effect of insulin on hIAPP fibril formation has been observed in vitro [<xref ref-type="bibr" rid="B76">76</xref>&#x02013;<xref ref-type="bibr" rid="B78">78</xref>]. On the other hand, a changing lipid composition of the <italic>&#x003b2;</italic>-cells, in particular an increase in negatively charged lipids as inferred from studies with mouse and rat models for DM2 [<xref ref-type="bibr" rid="B79">79</xref>], could also trigger an increase in hIAPP-membrane interactions. In vitro studies show that negatively charged lipids increase the rate of hIAPP fibril formation [<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B50">50</xref>] and also enhance hIAPP-induced membrane damage [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B51">51</xref>]. The membrane itself could promote hIAPP growth by increasing the local concentration of (membrane bound) hIAPP and/or by promoting a specific orientation or conformation of the peptide that makes hIAPP molecules more susceptible to aggregation into oligomers or fibrils. Recent research shows that not only phospholipid bilayers, but also a polyanion like heparin [<xref ref-type="bibr" rid="B80">80</xref>] or a dichloromethane/water interface [<xref ref-type="bibr" rid="B22">22</xref>] can induce nucleation and aggregation of hIAPP. These results indicate that charge and a hydrophobic/hydrophilic interface (both present in biological membranes) are important factors that promote hIAPP fibril formation.</p></sec><sec sec-type="section" id="sec6"><title>6. FUTURE PERSPECTIVES AND CHALLENGES</title><p>During the last years, the understanding of hIAPP-membrane interactions has significantly increased. We have now important indications that oligomeric hIAPP, in contrast to fibrillar hIAPP, is the main species involved in membrane damage and is a likely candidate to cause <italic>&#x003b2;</italic>-cell death in DM2. However, in a cellular environment, such toxic oligomers have not (yet) been directly demonstrated. More insight is required into the question whether hIAPP oligomers are inherently cytotoxic and persist as toxic oligomer after their cytotoxic action, or whether they are transient participants in the process of fibril growth at the membrane. A major challenge is to elucidate the mechanism by which hIAPP induces membrane damage and cytotoxicity. This knowledge would be essential to develop new strategies to battle hIAPP-induced <italic>&#x003b2;</italic>-cell death in DM2. Determination of the three-dimensional structure of membrane disrupting hIAPP would be an important contribution in elucidation of the cytotoxic mechanism. Moreover, the importance of hIAPP-membrane interactions, discussed here, indicates that inhibition or alteration of hIAPP-membrane interactions might be an alternative strategy to reduce amyloid cytotoxicity and to prevent <italic>&#x003b2;</italic>-cell death in DM2, in addition to the &#x0201c;traditional strategy&#x0201d; to reduce amyloid by the development of molecules that inhibit amyloid fibril formation.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This research was financially supported by the Dutch Diabetes Research Foundation (Grant no. 2002.00.019). Lucie Khemt&#x000e9;mourian was supported by the European Commission (Marie Curie Postdoctoral fellowship).</p></ack><ref-list><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P</given-names></name></person-group><article-title>Fine structure of islets of Langerhans in insular amyloidosis</article-title><source><italic>Virchows Archiv A</italic></source><year>1973</year><volume>359</volume><issue>1</issue><fpage>1</fpage><lpage>18</lpage></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P</given-names></name><name><surname>Wernstedt</surname><given-names>C</given-names></name><name><surname>Wilander</surname><given-names>E</given-names></name><name><surname>Hayden</surname><given-names>DW</given-names></name><name><surname>O'Brien</surname><given-names>TD</given-names></name><name><surname>Johnson</surname><given-names>KH</given-names></name></person-group><article-title>Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1987</year><volume>84</volume><issue>11</issue><fpage>3881</fpage><lpage>3885</lpage><pub-id pub-id-type="pmid">3035556</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>GJS</given-names></name><name><surname>Willis</surname><given-names>AC</given-names></name><name><surname>Clark</surname><given-names>A</given-names></name><name><surname>Turner</surname><given-names>RC</given-names></name><name><surname>Sim</surname><given-names>RB</given-names></name><name><surname>Reid</surname><given-names>KBM</given-names></name></person-group><article-title>Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1987</year><volume>84</volume><issue>23</issue><fpage>8628</fpage><lpage>8632</lpage><pub-id pub-id-type="pmid">3317417</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>CE</given-names></name><name><surname>Willis</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes</article-title><source><italic>The Lancet</italic></source><year>1987</year><volume>330</volume><issue>8553</issue><fpage>231</fpage><lpage>234</lpage></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo</surname><given-names>A</given-names></name><name><surname>Razzaboni</surname><given-names>B</given-names></name><name><surname>Weir</surname><given-names>GC</given-names></name><name><surname>Yankner</surname><given-names>BA</given-names></name></person-group><article-title>Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus</article-title><source><italic>Nature</italic></source><year>1994</year><volume>368</volume><issue>6473</issue><fpage>756</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">8152488</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>TD</given-names></name><name><surname>Butler</surname><given-names>PC</given-names></name><name><surname>Kreutter</surname><given-names>DK</given-names></name><name><surname>Kane</surname><given-names>LA</given-names></name><name><surname>Eberhardt</surname><given-names>NL</given-names></name></person-group><article-title>Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis</article-title><source><italic>American Journal of Pathology</italic></source><year>1995</year><volume>147</volume><issue>3</issue><fpage>609</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">7677175</pub-id></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janson</surname><given-names>J</given-names></name><name><surname>Ashley</surname><given-names>RH</given-names></name><name><surname>Harrison</surname><given-names>D</given-names></name><name><surname>McIntyre</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>PC</given-names></name></person-group><article-title>The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles</article-title><source><italic>Diabetes</italic></source><year>1999</year><volume>48</volume><issue>3</issue><fpage>491</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">10078548</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiddinga</surname><given-names>HJ</given-names></name><name><surname>Eberhardt</surname><given-names>NL</given-names></name></person-group><article-title>Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells</article-title><source><italic>American Journal of Pathology</italic></source><year>1999</year><volume>154</volume><issue>4</issue><fpage>1077</fpage><lpage>1088</lpage><pub-id pub-id-type="pmid">10233846</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saafi</surname><given-names>EL</given-names></name><name><surname>Konarkowska</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Kistler</surname><given-names>J</given-names></name><name><surname>Cooper</surname><given-names>GJS</given-names></name></person-group><article-title>Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet <italic>&#x003b2;</italic>-cells</article-title><source><italic>Cell Biology International</italic></source><year>2001</year><volume>25</volume><issue>4</issue><fpage>339</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">11319840</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Betsholtz</surname><given-names>C</given-names></name><name><surname>Christmansson</surname><given-names>L</given-names></name><name><surname>Engstr&#x000f6;m</surname><given-names>U</given-names></name><etal/></person-group><article-title>Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species</article-title><source><italic>FEBS Letters</italic></source><year>1989</year><volume>251</volume><issue>1-2</issue><fpage>261</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">2666169</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>H&#x000f6;ppener</surname><given-names>JWM</given-names></name><name><surname>Oosterwijk</surname><given-names>C</given-names></name><name><surname>Nieuwenhuis</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model</article-title><source><italic>Diabetologia</italic></source><year>1999</year><volume>42</volume><issue>4</issue><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">10230646</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P</given-names></name><name><surname>Engstr&#x000f6;m</surname><given-names>U</given-names></name><name><surname>Johnson</surname><given-names>KH</given-names></name><name><surname>Westermark</surname><given-names>GT</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name></person-group><article-title>Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1990</year><volume>87</volume><issue>13</issue><fpage>5036</fpage><lpage>5040</lpage><pub-id pub-id-type="pmid">2195544</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charg&#x000e9;</surname><given-names>SBP</given-names></name><name><surname>de Koning</surname><given-names>EJP</given-names></name><name><surname>Clark</surname><given-names>A</given-names></name></person-group><article-title>Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro</article-title><source><italic>Biochemistry</italic></source><year>1995</year><volume>34</volume><issue>44</issue><fpage>14588</fpage><lpage>14593</lpage><pub-id pub-id-type="pmid">7578065</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kapurniotu</surname><given-names>A</given-names></name><name><surname>Bernhagen</surname><given-names>J</given-names></name><name><surname>Greenfield</surname><given-names>N</given-names></name><etal/></person-group><article-title>Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide</article-title><source><italic>European Journal of Biochemistry</italic></source><year>1998</year><volume>251</volume><issue>1-2</issue><fpage>208</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">9492286</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kayed</surname><given-names>R</given-names></name><name><surname>Bernhagen</surname><given-names>J</given-names></name><name><surname>Greenfield</surname><given-names>N</given-names></name><etal/></person-group><article-title>Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro</article-title><source><italic>Journal of Molecular Biology</italic></source><year>1999</year><volume>287</volume><issue>4</issue><fpage>781</fpage><lpage>796</lpage><pub-id pub-id-type="pmid">10191146</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaikaran</surname><given-names>ETAS</given-names></name><name><surname>Higham</surname><given-names>CE</given-names></name><name><surname>Serpell</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Identification of a novel human islet amyloid polypeptide <italic>&#x003b2;</italic>-sheet domain and factors influencing fibrillogenesis</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2001</year><volume>308</volume><issue>3</issue><fpage>515</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">11327784</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padrick</surname><given-names>SB</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2001</year><volume>308</volume><issue>4</issue><fpage>783</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">11350174</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padrick</surname><given-names>SB</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis</article-title><source><italic>Biochemistry</italic></source><year>2002</year><volume>41</volume><issue>14</issue><fpage>4694</fpage><lpage>4703</lpage><pub-id pub-id-type="pmid">11926832</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>JL</given-names></name><name><surname>Ko</surname><given-names>E</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry</article-title><source><italic>Protein Science</italic></source><year>2000</year><volume>9</volume><issue>2</issue><fpage>427</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">10716196</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>BW</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Contribution of the intrinsic disulfide to the assembly mechanism of islet amyloid</article-title><source><italic>Protein Science</italic></source><year>2005</year><volume>14</volume><issue>1</issue><fpage>231</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">15576552</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>JA</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Direct detection of transient <italic>&#x003b1;</italic>-helical states in islet amyloid polypeptide</article-title><source><italic>Protein Science</italic></source><year>2007</year><volume>16</volume><issue>1</issue><fpage>110</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">17123962</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruschak</surname><given-names>AM</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Fiber-dependent amyloid formation as catalysis of an existing reaction pathway</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2007</year><volume>104</volume><issue>30</issue><fpage>12341</fpage><lpage>12346</lpage><pub-id pub-id-type="pmid">17640888</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harper</surname><given-names>JD</given-names></name><name><surname>Lansbury</surname><given-names>PT</given-names><suffix>Jr</suffix></name></person-group><article-title>Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins</article-title><source><italic>Annual Review of Biochemistry</italic></source><year>1997</year><volume>66</volume><fpage>385</fpage><lpage>407</lpage></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naiki</surname><given-names>H</given-names></name><name><surname>Higuchi</surname><given-names>K</given-names></name><name><surname>Hosokawa</surname><given-names>M</given-names></name><name><surname>Takeda</surname><given-names>T</given-names></name></person-group><article-title>Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T</article-title><source><italic>Analytical Biochemistry</italic></source><year>1989</year><volume>177</volume><issue>2</issue><fpage>244</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">2729542</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>LR</given-names></name><name><surname>Balasubramaniam</surname><given-names>A</given-names></name></person-group><article-title>Promotion of <italic>&#x003b2;</italic>-structure by interaction of diabetes associated polypeptide (amylin) with phosphatidylcholine</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>1992</year><volume>1122</volume><issue>3</issue><fpage>317</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">1504094</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldsbury</surname><given-names>C</given-names></name><name><surname>Goldie</surname><given-names>K</given-names></name><name><surname>Pellaud</surname><given-names>J</given-names></name><etal/></person-group><article-title>Amyloid fibril formation from full-length and fragments of amylin</article-title><source><italic>Journal of Structural Biology</italic></source><year>2000</year><volume>130</volume><issue>2-3</issue><fpage>352</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">10940238</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jayasinghe</surname><given-names>SA</given-names></name><name><surname>Langen</surname><given-names>R</given-names></name></person-group><article-title>Lipid membranes modulate the structure of islet amyloid polypeptide</article-title><source><italic>Biochemistry</italic></source><year>2005</year><volume>44</volume><issue>36</issue><fpage>12113</fpage><lpage>12119</lpage><pub-id pub-id-type="pmid">16142909</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>JD</given-names></name><name><surname>Hebda</surname><given-names>JA</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Conserved and cooperative assembly of membrane-bound <italic>&#x003b1;</italic>-helical states of islet amyloid polypeptide</article-title><source><italic>Biochemistry</italic></source><year>2006</year><volume>45</volume><issue>31</issue><fpage>9496</fpage><lpage>9508</lpage><pub-id pub-id-type="pmid">16878984</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anguiano</surname><given-names>M</given-names></name><name><surname>Nowak</surname><given-names>RJ</given-names></name><name><surname>Lansbury</surname><given-names>PT</given-names><suffix>Jr</suffix></name></person-group><article-title>Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes</article-title><source><italic>Biochemistry</italic></source><year>2002</year><volume>41</volume><issue>38</issue><fpage>11338</fpage><lpage>11343</lpage><pub-id pub-id-type="pmid">12234175</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>JD</given-names></name><name><surname>Goldsbury</surname><given-names>C</given-names></name><name><surname>Kistler</surname><given-names>J</given-names></name><name><surname>Cooper</surname><given-names>GJS</given-names></name><name><surname>Aebi</surname><given-names>U</given-names></name></person-group><article-title>Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2004</year><volume>279</volume><issue>13</issue><fpage>12206</fpage><lpage>12212</lpage><pub-id pub-id-type="pmid">14704152</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kayed</surname><given-names>R</given-names></name><name><surname>Sokolov</surname><given-names>Y</given-names></name><name><surname>Edmonds</surname><given-names>B</given-names></name><etal/></person-group><article-title>Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2004</year><volume>279</volume><issue>45</issue><fpage>46363</fpage><lpage>46366</lpage><pub-id pub-id-type="pmid">15385542</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rochet</surname><given-names>J-C</given-names></name><name><surname>Conway</surname><given-names>KA</given-names></name><name><surname>Lansbury</surname><given-names>PT</given-names><suffix>Jr</suffix></name></person-group><article-title>Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse <italic>&#x003b1;</italic>-synuclein</article-title><source><italic>Biochemistry</italic></source><year>2000</year><volume>39</volume><issue>35</issue><fpage>10619</fpage><lpage>10626</lpage><pub-id pub-id-type="pmid">10978144</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glabe</surname><given-names>CG</given-names></name><name><surname>Kayed</surname><given-names>R</given-names></name></person-group><article-title>Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis</article-title><source><italic>Neurology</italic></source><year>2006</year><volume>66</volume><issue>2</issue><supplement>supplement 1</supplement><fpage>S74</fpage><lpage>S78</lpage><pub-id pub-id-type="pmid">16432151</pub-id></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kayed</surname><given-names>R</given-names></name><name><surname>Head</surname><given-names>E</given-names></name><name><surname>Thompson</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis</article-title><source><italic>Science</italic></source><year>2003</year><volume>300</volume><issue>5618</issue><fpage>486</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">12702875</pub-id></citation></ref><ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldsbury</surname><given-names>C</given-names></name><name><surname>Cooper</surname><given-names>GJS</given-names></name><name><surname>Goldie</surname><given-names>KN</given-names></name><etal/></person-group><article-title>Polymorphic fibrillar assembly of human amylin</article-title><source><italic>Journal of Structural Biology</italic></source><year>1997</year><volume>119</volume><issue>1</issue><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">9216085</pub-id></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sumner Makin</surname><given-names>O</given-names></name><name><surname>Serpell</surname><given-names>LC</given-names></name></person-group><article-title>Structural characterisation of islet amyloid polypeptide fibrils</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2004</year><volume>335</volume><issue>5</issue><fpage>1279</fpage><lpage>1288</lpage><pub-id pub-id-type="pmid">14729343</pub-id></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jayasinghe</surname><given-names>SA</given-names></name><name><surname>Langen</surname><given-names>R</given-names></name></person-group><article-title>Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2004</year><volume>279</volume><issue>46</issue><fpage>48420</fpage><lpage>48425</lpage><pub-id pub-id-type="pmid">15358791</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawaya</surname><given-names>MR</given-names></name><name><surname>Sambashivan</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>R</given-names></name><etal/></person-group><article-title>Atomic structures of amyloid cross-<italic>&#x003b2;</italic> spines reveal varied steric zippers</article-title><source><italic>Nature</italic></source><year>2007</year><volume>447</volume><issue>7143</issue><fpage>453</fpage><lpage>457</lpage><pub-id pub-id-type="pmid">17468747</pub-id></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moriarty</surname><given-names>DF</given-names></name><name><surname>Raleigh</surname><given-names>DP</given-names></name></person-group><article-title>Effects of sequential proline substitutions on amyloid formation by human amylin<sub>20&#x02013;29</sub></article-title><source><italic>Biochemistry</italic></source><year>1999</year><volume>38</volume><issue>6</issue><fpage>1811</fpage><lpage>1818</lpage><pub-id pub-id-type="pmid">10026261</pub-id></citation></ref><ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rijkers</surname><given-names>DTS</given-names></name><name><surname>H&#x000f6;ppener</surname><given-names>JWM</given-names></name><name><surname>Posthuma</surname><given-names>G</given-names></name><name><surname>Lips</surname><given-names>CJM</given-names></name><name><surname>Liskamp</surname><given-names>RMJ</given-names></name></person-group><article-title>Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and <italic>&#x003b1;</italic>-hydroxy acid residue containing peptides</article-title><source><italic>Chemistry: A European Journal</italic></source><year>2002</year><volume>8</volume><issue>18</issue><fpage>4285</fpage><lpage>4291</lpage></citation></ref><ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porat</surname><given-names>Y</given-names></name><name><surname>Mazor</surname><given-names>Y</given-names></name><name><surname>Efrat</surname><given-names>S</given-names></name><name><surname>Gazit</surname><given-names>E</given-names></name></person-group><article-title>Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions</article-title><source><italic>Biochemistry</italic></source><year>2004</year><volume>43</volume><issue>45</issue><fpage>14454</fpage><lpage>14462</lpage><pub-id pub-id-type="pmid">15533050</pub-id></citation></ref><ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>L-M</given-names></name><name><surname>Tatarek-Nossol</surname><given-names>M</given-names></name><name><surname>Velkova</surname><given-names>A</given-names></name><name><surname>Kazantzis</surname><given-names>A</given-names></name><name><surname>Kapurniotu</surname><given-names>A</given-names></name></person-group><article-title>Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2006</year><volume>103</volume><issue>7</issue><fpage>2046</fpage><lpage>2051</lpage><pub-id pub-id-type="pmid">16467158</pub-id></citation></ref><ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abedini</surname><given-names>A</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Raleigh</surname><given-names>DP</given-names></name></person-group><article-title>A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor</article-title><source><italic>Journal of the American Chemical Society</italic></source><year>2007</year><volume>129</volume><issue>37</issue><fpage>11300</fpage><lpage>11301</lpage><pub-id pub-id-type="pmid">17722920</pub-id></citation></ref><ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Azriel</surname><given-names>R</given-names></name><name><surname>Gazit</surname><given-names>E</given-names></name></person-group><article-title>Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide&#x02014;an experimental support for the key role of the phenylalanine residue in amyloid formation</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>36</issue><fpage>34156</fpage><lpage>34161</lpage><pub-id pub-id-type="pmid">11445568</pub-id></citation></ref><ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marek</surname><given-names>P</given-names></name><name><surname>Abedini</surname><given-names>A</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><etal/></person-group><article-title>Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology</article-title><source><italic>Biochemistry</italic></source><year>2007</year><volume>46</volume><issue>11</issue><fpage>3255</fpage><lpage>3261</lpage><pub-id pub-id-type="pmid">17311418</pub-id></citation></ref><ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazor</surname><given-names>Y</given-names></name><name><surname>Gilead</surname><given-names>S</given-names></name><name><surname>Benhar</surname><given-names>I</given-names></name><name><surname>Gazit</surname><given-names>E</given-names></name></person-group><article-title>Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2002</year><volume>322</volume><issue>5</issue><fpage>1013</fpage><lpage>1024</lpage><pub-id pub-id-type="pmid">12367525</pub-id></citation></ref><ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scrocchi</surname><given-names>LA</given-names></name><name><surname>Ha</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Fraser</surname><given-names>PE</given-names></name></person-group><article-title>Identification of minimal peptide sequences in the (8&#x02013;20) domain of human islet amyloid polypeptide involved in fibrillogenesis</article-title><source><italic>Journal of Structural Biology</italic></source><year>2003</year><volume>141</volume><issue>3</issue><fpage>218</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">12648568</pub-id></citation></ref><ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abedini</surname><given-names>A</given-names></name><name><surname>Raleigh</surname><given-names>DP</given-names></name></person-group><article-title>The role of His-18 in amyloid formation by human islet amyloid polypeptide</article-title><source><italic>Biochemistry</italic></source><year>2005</year><volume>44</volume><issue>49</issue><fpage>16284</fpage><lpage>16291</lpage><pub-id pub-id-type="pmid">16331989</pub-id></citation></ref><ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>A</given-names></name><name><surname>Nilsson</surname><given-names>MR</given-names></name></person-group><article-title>Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes?</article-title><source><italic>Diabetologia</italic></source><year>2004</year><volume>47</volume><issue>2</issue><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">14722650</pub-id></citation></ref><ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>JD</given-names></name><name><surname>Miranker</surname><given-names>AD</given-names></name></person-group><article-title>Phospholipid catalysis of diabetic amyloid assembly</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2004</year><volume>341</volume><issue>5</issue><fpage>1175</fpage><lpage>1187</lpage><pub-id pub-id-type="pmid">15321714</pub-id></citation></ref><ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sparr</surname><given-names>E</given-names></name><name><surname>Engel</surname><given-names>MFM</given-names></name><name><surname>Sakharov</surname><given-names>DV</given-names></name><etal/></person-group><article-title>Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers</article-title><source><italic>FEBS Letters</italic></source><year>2004</year><volume>577</volume><issue>1-2</issue><fpage>117</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">15527771</pub-id></citation></ref><ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>DHJ</given-names></name><name><surname>Meister</surname><given-names>A</given-names></name><name><surname>Gohlke</surname><given-names>A</given-names></name><name><surname>Hauser</surname><given-names>A</given-names></name><name><surname>Blume</surname><given-names>A</given-names></name><name><surname>Winter</surname><given-names>R</given-names></name></person-group><article-title>Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy</article-title><source><italic>Biophysical Journal</italic></source><year>2007</year><volume>93</volume><issue>9</issue><fpage>3132</fpage><lpage>3141</lpage><pub-id pub-id-type="pmid">17660321</pub-id></citation></ref><ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quist</surname><given-names>A</given-names></name><name><surname>Doudevski</surname><given-names>I</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><etal/></person-group><article-title>Amyloid ion channels: a common structural link for protein-misfolding disease</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2005</year><volume>102</volume><issue>30</issue><fpage>10427</fpage><lpage>10432</lpage><pub-id pub-id-type="pmid">16020533</pub-id></citation></ref><ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>MFM</given-names></name><name><surname>Yigittop</surname><given-names>H</given-names></name><name><surname>Elgersma</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Islet amyloid polypeptide inserts into phospholipid monolayers as monomer</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2006</year><volume>356</volume><issue>3</issue><fpage>783</fpage><lpage>789</lpage><pub-id pub-id-type="pmid">16403520</pub-id></citation></ref><ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arispe</surname><given-names>N</given-names></name><name><surname>Pollard</surname><given-names>HB</given-names></name><name><surname>Rojas</surname><given-names>E</given-names></name></person-group><article-title>Giant multilevel cation channels formed by Alzheimer disease amyloid <italic>&#x003b2;</italic>-protein [A<italic>&#x003b2;</italic>P-(1&#x02013;40)] in bilayer membranes</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1993</year><volume>90</volume><issue>22</issue><fpage>10573</fpage><lpage>10577</lpage><pub-id pub-id-type="pmid">7504270</pub-id></citation></ref><ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arispe</surname><given-names>N</given-names></name><name><surname>Pollard</surname><given-names>HB</given-names></name><name><surname>Rojas</surname><given-names>E</given-names></name></person-group><article-title>The ability of amyloid <italic>&#x003b2;</italic>-protein [A<italic>&#x003b2;</italic>P (1&#x02013;40)] to form Ca<sup>2+</sup> channels provides a mechanism for neuronal death in Alzheimer's disease</article-title><source><italic>Annals of the New York Academy of Sciences</italic></source><year>1994</year><volume>747</volume><fpage>256</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">7847675</pub-id></citation></ref><ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mirzabekov</surname><given-names>TA</given-names></name><name><surname>Lin</surname><given-names>M-C</given-names></name><name><surname>Kagan</surname><given-names>BL</given-names></name></person-group><article-title>Pore formation by the cytotoxic islet amyloid peptide amylin</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>1996</year><volume>271</volume><issue>4</issue><fpage>1988</fpage><lpage>1992</lpage><pub-id pub-id-type="pmid">8567648</pub-id></citation></ref><ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Konarkowska</surname><given-names>B</given-names></name><name><surname>Aitken</surname><given-names>JF</given-names></name><name><surname>Kistler</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Cooper</surname><given-names>GJS</given-names></name></person-group><article-title>The aggregation potential of human amylin determines its cytotoxicity towards islet <italic>&#x003b2;</italic>-cells</article-title><source><italic>FEBS Journal</italic></source><year>2006</year><volume>273</volume><issue>15</issue><fpage>3614</fpage><lpage>3624</lpage><pub-id pub-id-type="pmid">16884500</pub-id></citation></ref><ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demuro</surname><given-names>A</given-names></name><name><surname>Mina</surname><given-names>E</given-names></name><name><surname>Kayed</surname><given-names>R</given-names></name><name><surname>Milton</surname><given-names>SC</given-names></name><name><surname>Parker</surname><given-names>I</given-names></name><name><surname>Glabe</surname><given-names>CG</given-names></name></person-group><article-title>Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2005</year><volume>280</volume><issue>17</issue><fpage>17294</fpage><lpage>17300</lpage><pub-id pub-id-type="pmid">15722360</pub-id></citation></ref><ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porat</surname><given-names>Y</given-names></name><name><surname>Kolusheva</surname><given-names>S</given-names></name><name><surname>Jelinek</surname><given-names>R</given-names></name><name><surname>Gazit</surname><given-names>E</given-names></name></person-group><article-title>The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies</article-title><source><italic>Biochemistry</italic></source><year>2003</year><volume>42</volume><issue>37</issue><fpage>10971</fpage><lpage>10977</lpage><pub-id pub-id-type="pmid">12974632</pub-id></citation></ref><ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balali-Mood</surname><given-names>K</given-names></name><name><surname>Ashley</surname><given-names>RH</given-names></name><name><surname>Hau&#x000df;</surname><given-names>T</given-names></name><name><surname>Bradshaw</surname><given-names>JP</given-names></name></person-group><article-title>Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin</article-title><source><italic>FEBS Letters</italic></source><year>2005</year><volume>579</volume><issue>5</issue><fpage>1143</fpage><lpage>1148</lpage><pub-id pub-id-type="pmid">15710403</pub-id></citation></ref><ref id="B62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harroun</surname><given-names>TA</given-names></name><name><surname>Bradshaw</surname><given-names>JP</given-names></name><name><surname>Ashley</surname><given-names>RH</given-names></name></person-group><article-title>Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation</article-title><source><italic>FEBS Letters</italic></source><year>2001</year><volume>507</volume><issue>2</issue><fpage>200</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">11684098</pub-id></citation></ref><ref id="B63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>JD</given-names></name><name><surname>Kreplak</surname><given-names>L</given-names></name><name><surname>Goldsbury</surname><given-names>C</given-names></name><etal/></person-group><article-title>Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide</article-title><source><italic>Journal of Molecular Biology</italic></source><year>2004</year><volume>342</volume><issue>3</issue><fpage>877</fpage><lpage>887</lpage><pub-id pub-id-type="pmid">15342243</pub-id></citation></ref><ref id="B64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>JJ</given-names></name><name><surname>Kayed</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>C-Y</given-names></name><etal/></person-group><article-title>Inhibition of human IAPP fibril formation does not prevent <italic>&#x003b2;</italic>-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP</article-title><source><italic>American Journal of Physiology</italic></source><year>2006</year><volume>291</volume><issue>6</issue><fpage>E1317</fpage><lpage>E1324</lpage><pub-id pub-id-type="pmid">16849627</pub-id></citation></ref><ref id="B65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bucciantini</surname><given-names>M</given-names></name><name><surname>Giannoni</surname><given-names>E</given-names></name><name><surname>Chiti</surname><given-names>F</given-names></name><etal/></person-group><article-title>Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases</article-title><source><italic>Nature</italic></source><year>2002</year><volume>416</volume><issue>6880</issue><fpage>507</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">11932737</pub-id></citation></ref><ref id="B66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kourie</surname><given-names>JI</given-names></name><name><surname>Culverson</surname><given-names>AL</given-names></name><name><surname>Farrelly</surname><given-names>PV</given-names></name><name><surname>Henry</surname><given-names>CL</given-names></name><name><surname>Laohachai</surname><given-names>KN</given-names></name></person-group><article-title>Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis</article-title><source><italic>Cell Biochemistry and Biophysics</italic></source><year>2002</year><volume>36</volume><issue>2-3</issue><fpage>191</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">12139405</pub-id></citation></ref><ref id="B67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brender</surname><given-names>JR</given-names></name><name><surname>D&#x000fc;rr</surname><given-names>UHN</given-names></name><name><surname>Heyl</surname><given-names>D</given-names></name><name><surname>Budarapu</surname><given-names>MB</given-names></name><name><surname>Ramamoorthy</surname><given-names>A</given-names></name></person-group><article-title>Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2007</year><volume>1768</volume><issue>9</issue><fpage>2026</fpage><lpage>2029</lpage><pub-id pub-id-type="pmid">17662957</pub-id></citation></ref><ref id="B68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C-J</given-names></name><name><surname>Lin</surname><given-names>C-Y</given-names></name><name><surname>Haataja</surname><given-names>L</given-names></name><etal/></person-group><article-title>High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress-mediated <italic>&#x003b2;</italic>-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes</article-title><source><italic>Diabetes</italic></source><year>2007</year><volume>56</volume><issue>8</issue><fpage>2016</fpage><lpage>2027</lpage><pub-id pub-id-type="pmid">17475933</pub-id></citation></ref><ref id="B69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C-Y</given-names></name><name><surname>Gurlo</surname><given-names>T</given-names></name><name><surname>Kayed</surname><given-names>R</given-names></name><etal/></person-group><article-title>Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced <italic>&#x003b2;</italic>-cell apoptosis in h-IAPP transgenic mice</article-title><source><italic>Diabetes</italic></source><year>2007</year><volume>56</volume><issue>5</issue><fpage>1324</fpage><lpage>1332</lpage><pub-id pub-id-type="pmid">17353506</pub-id></citation></ref><ref id="B70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrikopoulos</surname><given-names>S</given-names></name><name><surname>Verchere</surname><given-names>CB</given-names></name><name><surname>Teague</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Two novel immortal pancreatic <italic>&#x003b2;</italic>-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid</article-title><source><italic>Diabetes</italic></source><year>1999</year><volume>48</volume><issue>10</issue><fpage>1962</fpage><lpage>1970</lpage><pub-id pub-id-type="pmid">10512360</pub-id></citation></ref><ref id="B71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>MFM</given-names></name><name><surname>Kh&#x000e9;mtemourian</surname><given-names>L</given-names></name><name><surname>Kleijer</surname><given-names>C</given-names></name><etal/></person-group><article-title>Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane</article-title><comment><italic>Proceedings of the National Academy of Sciences of the United States of America</italic>. In press</comment></citation></ref><ref id="B72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wogulis</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>S</given-names></name><name><surname>Cunningham</surname><given-names>D</given-names></name><name><surname>Chilcote</surname><given-names>T</given-names></name><name><surname>Powell</surname><given-names>K</given-names></name><name><surname>Rydel</surname><given-names>RE</given-names></name></person-group><article-title>Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death</article-title><source><italic>Journal of Neuroscience</italic></source><year>2005</year><volume>25</volume><issue>5</issue><fpage>1071</fpage><lpage>1080</lpage><pub-id pub-id-type="pmid">15689542</pub-id></citation></ref><ref id="B73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Jutila</surname><given-names>A</given-names></name><name><surname>Nurminen</surname><given-names>T</given-names></name><name><surname>Wickstr&#x000f6;m</surname><given-names>SA</given-names></name><name><surname>Keski-Oja</surname><given-names>J</given-names></name><name><surname>Kinnunen</surname><given-names>PKJ</given-names></name></person-group><article-title>Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers</article-title><source><italic>Biochemistry</italic></source><year>2005</year><volume>44</volume><issue>8</issue><fpage>2857</fpage><lpage>2863</lpage><pub-id pub-id-type="pmid">15723529</pub-id></citation></ref><ref id="B74"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Tuominen</surname><given-names>EKJ</given-names></name><name><surname>Kinnunen</surname><given-names>PKJ</given-names></name></person-group><article-title>Formation of amyloid fibers triggered by phosphatidylserine-containing membranes</article-title><source><italic>Biochemistry</italic></source><year>2004</year><volume>43</volume><issue>32</issue><fpage>10302</fpage><lpage>10307</lpage><pub-id pub-id-type="pmid">15301528</pub-id></citation></ref><ref id="B75"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gellermann</surname><given-names>GP</given-names></name><name><surname>Appel</surname><given-names>TR</given-names></name><name><surname>Tannert</surname><given-names>A</given-names></name><etal/></person-group><article-title>Raft lipids as common components of human extracellular amyloid fibrils</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2005</year><volume>102</volume><issue>18</issue><fpage>6297</fpage><lpage>6302</lpage><pub-id pub-id-type="pmid">15851687</pub-id></citation></ref><ref id="B76"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilead</surname><given-names>S</given-names></name><name><surname>Wolfenson</surname><given-names>H</given-names></name><name><surname>Gazit</surname><given-names>E</given-names></name></person-group><article-title>Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin</article-title><source><italic>Angewandte Chemie International Edition</italic></source><year>2006</year><volume>45</volume><issue>39</issue><fpage>6476</fpage><lpage>6480</lpage></citation></ref><ref id="B77"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westermark</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>Z-C</given-names></name><name><surname>Westermark</surname><given-names>GT</given-names></name><name><surname>Leckstr&#x000f6;m</surname><given-names>A</given-names></name><name><surname>Steiner</surname><given-names>DF</given-names></name></person-group><article-title>Effects of <italic>&#x003b2;</italic> cell granule components on human islet amyloid polypeptide fibril formation</article-title><source><italic>FEBS Letters</italic></source><year>1996</year><volume>379</volume><issue>3</issue><fpage>203</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">8603689</pub-id></citation></ref><ref id="B78"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaikaran</surname><given-names>ETAS</given-names></name><name><surname>Nilsson</surname><given-names>MR</given-names></name><name><surname>Clark</surname><given-names>A</given-names></name></person-group><article-title>Pancreatic <italic>&#x003b2;</italic>-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation</article-title><source><italic>Biochemical Journal</italic></source><year>2004</year><volume>377, part 3</volume><fpage>709</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">14565847</pub-id></citation></ref><ref id="B79"><label>79</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rustenbeck</surname><given-names>I</given-names></name><name><surname>Matthies</surname><given-names>A</given-names></name><name><surname>Lenzen</surname><given-names>S</given-names></name></person-group><article-title>Lipid composition of glucose-stimulated pancreatic islets and insulin-secreting tumor cells</article-title><source><italic>Lipids</italic></source><year>1994</year><volume>29</volume><issue>10</issue><fpage>685</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">7861935</pub-id></citation></ref><ref id="B80"><label>80</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Konno</surname><given-names>T</given-names></name><name><surname>Oiki</surname><given-names>S</given-names></name><name><surname>Morii</surname><given-names>T</given-names></name></person-group><article-title>Synergistic action of polyanionic and non-polar cofactors in fibrillation of human islet amyloid polypeptide</article-title><source><italic>FEBS Letters</italic></source><year>2007</year><volume>581</volume><issue>8</issue><fpage>1635</fpage><lpage>1638</lpage><pub-id pub-id-type="pmid">17399708</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Comparison of the amino acid sequences of human IAPP (hIAPP) and mouse IAPP (mIAPP). Mouse IAPP differs from the human peptide by six residues (in red). The rectangle shows the N-terminal region that is thought to be important for membrane interactions. The amino acid region suggested to be important for fibril formation is represented in the underlined.</p></caption><graphic xlink:href="EDR2008-421287.001"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Typical shape of the kinetics of hIAPP fibril formation, characterized by a lag phase and a sigmoidal transition. The approximate aggregation state of IAPP is indicated at the various time points. Fibril formation was induced by adding, at time 0, a monomeric stock solution of hIAPP in DMSO to buffer containing Thioflavin T.</p></caption><graphic xlink:href="EDR2008-421287.002"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Simplified schematic representation of the different models of hIAPP-membrane interaction in relation to membrane damage and hIAPP cytotoxicity. The red rectangles show the toxic species and the red arrows show the toxic processes according to different hypotheses. The black circle represents a phospholipid membrane (vesicle), the grey circles represent hIAPP monomers, and clusters of 4 or more circles represent hIAPP oligomers and hIAPP fibrils, respectively. Membrane damage is schematically indicated by the grey arrows. Model (1) includes two steps: (i) formation of soluble hIAPP oligomers, (ii) interaction of the toxic oligomers with the membrane leading to membrane damage. Model (2) includes three steps: (i) binding of monomeric, random coil hIAPP to the membrane and folding to <italic>&#x003b1;</italic>-helix, (ii) oligomer formation of membrane-bound hIAPP, and (iii) interaction of the toxic hIAPP oligomer with the membrane leading to membrane damage. Model (3) includes 3 steps: (i) interaction of monomeric and possibly oligomeric hIAPP to the membrane, (ii) growth of hIAPP fibrils at the membrane (red arrows) leading to a forced change in membrane morphology and concomitant membrane disruption, and (iii) detachment of mature fibrils from distorted membrane.</p></caption><graphic xlink:href="EDR2008-421287.003"/></fig></floats-wrap></article> 